VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Q1 2023 will be the first quarter with the full sales 33

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston May 31, 2023 3:20pm

119 Views

Post# 35473333

RE:RE:Q1 2023 will be the first quarter with the full sales 33

Boy! GrahamB spends a lot of time for a stock that he doesn't own and doesn't believe in!

I wonder why this specific stock though?

What he doesn't remember is that he posted that he was waiting this stock to touch 0.19$ before jumping in. So his constant FUD to try to get your shares on the cheap!

<< Previous

Bullboard Posts

Next >>

AI companies to invest in